Fingerprint
Dive into the research topics of 'Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer
Kensuke Kataoka, Ryujiro Suzuki, Hiroyuki Taniguchi, Yasunobu Noda, Joe Shindoh, Syuichi Matsumoto, Yoshiaki Watanabe, Kousuke Honda, Kiyoshi Suzuki, Kenji Baba, Kazuyoshi Imaizumi, Hiroaki Kume, Yoshinori Hasegawa, Kenzo Takagi
Research output: Contribution to journal › Article › peer-review
5
Citations
(Scopus)